StemCells, Inc. Terminates Its Discussions to Acquire Progenitor Cell Therapy, LLC
StemCells, Inc. has announced it is no longer pursuing a possible acquisition of Progenitor Cell Therapy, LLC, a leading provider of cGMP-quality cell processing services headquartered in Hackensack, NJ.
Article
PrimeGen Biotech LLC and Unidym, Inc. Form Alliance to Optimize Development of Induced Pluripotent Stem Cells
PrimeGen Biotech LLC and Unidym Inc. has announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine.
Article
StemCyte Announces Joint Venture With Two Leading Healthcare and Pharmaceutical Companies in India
The creation of a new venture, StemCyte India, continues StemCyte’s international expansion and utilizes the strengths and regional expertise of Apollo Hospitals and Cadila Pharmaceuticals.
Article
Advanced Cell Technology Announces Catheter Supply Agreement with Biologics Delivery Systems Group
Advanced Cell Technology, Inc. has announced that it has reached a supply agreement with Biologics Delivery Systems Group, Cordis Corporation, in which Biologics Delivery Systems will supply catheters for the Phase II human clinical trial of ACT’s myoblast therapy for the treatment of heart failure.
Article
Osteotech Signs Agreement To Distribute Harvest Technologies’ BMAC(TM) System
Osteotech, Inc. has announced that it has entered into a three-year agreement with Harvest Technologies Corporation to distribute the BMAC(TM) (Bone Marrow Aspirate Concentrate) System.
Article
Millipore and Guava Technologies Team Up to Create New Solutions for Fast Growing Cell Biology Market
Millipore Corporation and Guava Technologies, Inc. have announced a long-term partnership to deliver integrated flow cytometry solutions to scientists conducting research in cell biology, including stem cell research.
Article
Millipore Expands Portfolio of Animal-Free Cell Culture Supplements through Partnership with Solabia
Millipore Corporation has announced an agreement with Solabia S.A.S. to distribute animal-free hydrolysates to its biopharmaceutical customers.
Article
Exactech Signs License Agreement for Cartilage Repair Technology, Patent Rights
Exactech, Inc. has announced that its Taiwanese subsidiary, Exactech Taiwan, has entered into an exclusive license agreement with the Industrial Technology Research Institute and the National Taiwan University Hospital for the rights to technology and patents related to the repair of cartilage lesions.
Article
World-first Stem Cell Screening Facility to Target Brain Tumours
More effective treatments for brain cancer will be developed at a tumour-cell testing facility opened on Wednesday, March 5, at The University of Queensland’s Queensland Brain Institute.
Article
First Umbilical Cord Blood Bank to Be Set Up
The first umbilical cord blood bank will start its operation in Vietnam in late April.
Article
Stem Cell Funding for Parkinson’s Disease
The Parkinson’s Disease Society has announced funding of 170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals.
Article
TxCell Completes a 10.5 Million Second Round and Initiates Clinical Trials
This round of financing confirms the significant potential of TxCell’s innovative approach and will enable the company to determine the clinical efficacy of treatment with autologous Tr1 cells.
Article
Alnylam Announces Grant of Tuschl II Patent in Japan
Alnylam Pharmaceuticals, Inc. has announced that the Japanese Patent Office has sent notification of an intent to grant a patent (JP Application Number 2002/546670) for the Tuschl II patent series, entitled “RNA Interference Mediating Small RNA Molecules.”
Article
MicroIslet Announces New Scientific Advisory Board
The Company named John B. Buse, M.D., Ph.D., David W. Scharp, M.D., Christopher L. Marsh, M.D., F.A.C.S, Bassam Damaj, Ph.D., Miguel Carlos Riella, M.D., Ph.D., and John Logan, Ph.D. as members.
Article